NL-OMON26633
Recruiting
Not Applicable
Insight into bladder cancer care
Dutch Cancer Society (KWF Kankerbestrijding)0 sites6,500 target enrollmentTBD
ConditionsBladder cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Bladder cancer
- Sponsor
- Dutch Cancer Society (KWF Kankerbestrijding)
- Enrollment
- 6500
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All newly diagnosed Dutch patients with High\-Risk Non\-Muscle Invasive Bladder Cancer (HR\-NMIB; Cis and T1\) and Muscle invasive Bladder Cancer (MIBC; \=T2\) between November 1st 2017 and end 2019 in the Netherlands.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerTherapeutic area: Diseases [C] - Male Urogenital Diseases [C12]Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]CTIS2024-510865-41-00Aarhus Universitetshospital282
Recruiting
Not Applicable
Prospective Bladder Cancer Infrastructure - An infrastructure for observational and interventional bladder cancer researchbladder cancer10038364NL-OMON54621Stichting Prospectieve Blaaskanker Infrastructuur3,500
Completed
Not Applicable
Assessment of the role of the Xpert Bladder Cancer detect assay in patients with asymptomatic hematuriaR31D41.4C67Unspecified haematuriaBladderMalignant neoplasm of bladderDRKS00027469Cepheid Europe SAS400
Active, not recruiting
Not Applicable
rinary Xpert bladder cancer detection test in patients with haematuriaSuspected bladder cancerCancerMalignant neoplasm of bladderISRCTN40815027niversity of Dundee600
Active, not recruiting
Not Applicable
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220